Skip to main content
Signal8

Bispham Barbara Harlin

SEC insider (Form 3/4/5 filer). CIK 0002075230. Officer at CRESCENT BIOPHARMA, INC. (CBIO). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in WALTHAM, MA.

Companies Bispham Barbara Harlin has filed insider reports for

  • CRESCENT BIOPHARMA, INC. (CBIO): Officer, See Remarks
Bispham Barbara Harlin profile photo

Bispham Barbara Harlin

CIK: 0002075230

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRESCENT BIOPHARMA, INC. logo
CBIO

CRESCENT BIOPHARMA, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • CRESCENT BIOPHARMA, INC. logo
    CBIO

    CRESCENT BIOPHARMA, INC.

    Sep 16, 2026
    Sale
    Direct
    620 shares at avg. $17.90$11K
  • CRESCENT BIOPHARMA, INC. logo
    CBIO

    CRESCENT BIOPHARMA, INC.

    Jun 22, 2026
    Sale
    Direct
    1.2K shares at avg. $17.99$22K
  • CRESCENT BIOPHARMA, INC. logo
    CBIO

    CRESCENT BIOPHARMA, INC.

    Dec 15, 2025
    Award
    Direct
    12.4K shares-
  • CRESCENT BIOPHARMA, INC. logo
    CBIO

    CRESCENT BIOPHARMA, INC.

    Dec 15, 2025
    Award
    Direct
    6K shares-

1-4 of 4